O. Prem Das, PhDChief Research Business Development Officerprem_das@dfci.harvard.edu or 617-632-5893
Prem joined ORTV in 2012. His background includes managing academic technology transfer offices, biotechnology business development, and basic research. Most recently, Prem was involved in creating start-up companies and consulting to biotechnology companies and the NCI. Prior to this, he served as Senior Vice President for Technology Alliances at Praecis Pharmaceuticals, where his business development efforts led to the acquisition of the company by Glaxo-Smith Kline in 2007.
Before Praecis, from 2003 to 2006, Prem directed the Office of Technology Licensing at Harvard Medical School. From 2000 to 2003 he was Associate Director of the Office of Industrial Affairs at Memorial Sloan-Kettering Cancer Center. Earlier, he worked at Mount Sinai School of Medicine and Cadus Pharmaceuticals, and co-founded Heartland BioTechnologies. During his academic research career, Prem has published in diverse areas of biology. He received his MSc in Chemistry from IIT/Kanpur in India and his PhD in Biological Chemistry from MIT.
Gary M. Sclar, JD Associate Directorgary_sclar@dfci.harvard.edu or 617-632-5807
Before joining ORTV, Gary held the position of Chief Strategy Officer and Legal Counsel for MedMetrics Health Partners and Public Sector Partners. Gary has over 12 years of technology licensing experience, having worked in the technology licensing offices of Northeastern University, Brigham and Women’s Hospital, and the University of Massachusetts Medical School.
Prior to ORTV, Gary directed laboratories at Washington University School of Medicine and The Jackson Laboratory, specializing in nuclear transplantation and the generation of transgenic and embryonic stem cell knock-out animals. Gary has a Bachelor of Science degree from the University of Massachusetts, a Masters degree from Webster University School of Business, and a JD degree from Massachusetts School of Law. He is admitted to the Massachusetts Bar and Federal District Court.
Ruth Emyanitoff, PhDInternal Consultantruth_emyanitoff@dfci.harvard.edu or 617-632-4010
Ruth Emyanitoff has over 35 years of experience in academic technology transfer, biotechnology and biomedical business development, and research. She now serves as an internal consultant on special and complex projects. Ruth joined Dana-Farber in 1996 and became Director of the Office of Technology Transfer in 1997. After five years, she stepped aside from that position while continuing to work in the Office of Research and Technology Ventures as Senior Licensing Manager.
Prior to that, Ruth was Director of Business Development for 10 years at Therion Biologics and its predecessor company, Applied bioTechnology, which focused on vaccines for infectious diseases and cancer. She spent three years as a market research consultant with Boston Biomedical Consultants and one year at Genex Corporation in technology assessment. Ruth received an AB in Biological Sciences from the University of Chicago; an MS and PhD in Microbiology from Loyola University of Chicago; and postdoctoral training at the Boston Biomedical Research Institute.
Nancy N. Grodin, MA, MBALicensing Associatenancy_grodin@dfci.harvard.edu or 617-632-5516
Nancy joined Dana-Farber’s technology transfer and licensing group in 1999. She has worked with many Dana-Farber departments and strategic centers, including Medical Oncology, Cancer Immunology/AIDS, Cancer Biology, and the Center for Novel Experimental Therapeutics (C-NExT).
In recent years, Nancy has been involved with the formation of several start-up companies based on various technologies developed here at Dana-Farber. Nancy previously worked in the areas of market research and strategy development in the biotechnology industry. Prior to that, for over 10 years, she was a Senior Associate at the Strategic Planning Institute in Cambridge, Massachusetts, a consulting firm specializing in corporate strategic planning. Nancy has an MBA from Boston University, a Masters in Molecular Biology from UCLA, and a BS in Biology from SUNY Stony Brook.
Rudy Slovacek, PhDLicensing Associaterudolf_slovacek@dfci.harvard.edu or 617-632-5621
Rudy Slovacek joined the staff of ORTV as a Licensing Associate to service the Intellectual Property needs and contractual matters for investigators and physicians. He brings to ORTV an extensive background in industrial biomedical research and academic technology transfer. He received MS and PhD degrees in Biology from the University of Rochester, and conducted postdoctoral work at both the Naval Research Laboratory in Washington and Brookhaven National Laboratory.
Rudy worked for Corning Glass Works, where he helped to establish a satellite biomedical research facility in Cambridge, Massachusetts. As part of the Diagnostics Division of Corning, Ciba Corning and later Chiron, he worked on projects targeting inexpensive and easily manufactured sensors for a disposable bedside market. He is the holder of 16 US patents related to optical sensing technologies. Before joining Dana-Farber, he began his career change as a licensing professional in the Technology Transfer office at Boston Children’s Hospital.
Elena Vaillancourt, MAppSciLicensing Associateelena_vaillancourt@dfci.harvard.edu or 617-632-4018
Elena joined ORTV as a Licensing Associate in 2005. She works with many Dana-Farber departments and strategic centers, including investigators from Medical Oncology and Radiation Oncology, the Center for Functional Cancer Epigenetics (CFCE), and the Cell Manipulation Core Facility (CMCF). Elena has a strong interest in public health; she spent the earlier part of her career managing the Heath Promotion Center at Curtin University in Western Australia, and then lecturing in the Public Health undergraduate course at Deakin University in Melbourne. Upon moving to Boston in 1995, she became involved with managing epidemiological studies at the Mass. Eye and Ear Infirmary (MEEI) and the Harvard School of Public Health. She began her career in technology transfer in 1997 in the Office of Technology Licensing at Massachusetts General Hospital.
Elena has also worked at U-Mass Medical School in their Technology Licensing office. She has a BS in Biology and Psychology from Curtin University and a MAppSci in Public Health from Deakin University. Elena has been involved in several entrepreneurial ventures and in 2011 founded White Lion Baking Company, a paleo, grain-free bakery serving the US market, which she started, grew, and then successfully sold in May 2012.
Peter Hodges, PhDLicensing Associatepeter_hodges@dfci.harvard.edu or 617-632-4818
Peter joined Dana-Farber’s ORTV in August 2012 and manages IP from multiple departments.
After teaching at several Boston-area colleges, Peter joined Proteome, Inc., a start-up bioinformatics company. Following the acquisition of Proteome by Incyte Corporation, Peter moved to business development, and was involved in outlicensing Incyte’s vast patent portfolio. Peter transitioned to technology transfer at Boston Children’s Hospital in 2004 and handled a wide range of technologies, including research tools, bioinformatics and software, genetics, genomics and proteomics, cardiology, oncology, and stem cell technologies.
Peter received his PhD in Human Genetics from Yale University School of Medicine and did post-doctoral work in RNA biology in the UK at the Clinical Research Centre, Harrow, and at the University of Edinburgh.
Janet Ralbovsky, PhDLicensing AssociateJanetL_Ralbovsky@dfci.harvard.edu or 617-632-6058
Janet is currently a Licensing Associate in ORTV and manages chemistry-related Dana-Farber technologies. Previously, she was a Licensing Associate at the University of Tennessee Research Foundation (UTRF), where she was responsible for the commercialization of a broad portfolio of intellectual property developed at the University of Tennessee Health Science Center. Prior to joining UTRF, Janet worked in drug discovery as a medicinal chemist and project leader at Johnson & Johnson and Cara Therapeutics, Inc. Janet holds a PhD in Organic Chemistry from the Pennsylvania State University, a MS from the University of Rochester, and a BA from Smith College. She is a registered patent agent with the United States Patent and Trademark Office.
Michelle Erin JohnsonLicensing Associatemichellee_johnson@dfci.harvard.edu or 617-632-2118
Michelle joined ORTV in August 2011. She is a recent recipient of the 2013 Howard Bremer Scholarship, awarded by the Association of University Technology Managers (AUTM) to promising new professionals in the field of technology transfer.
Prior to joining Dana-Farber, Michelle worked for three years at Boston University in its Office of Research Compliance, where she administered the review and management of research conflicts of interest. She graduated cum laude from Boston University in 2008 with a BA in International Relations.
Inna Nusinzon, PhDTechnology Transfer Specialistinna_nusinzon@dfci.harvard.edu or 617-582-7223
Inna joined ORTV in 2013 as a Technology Transfer Specialist. She is also part of ORTV’s business development team, which liaises with industry partners to establish external scientific collaborations.
Inna received her PhD in Biochemistry and Biomedical Sciences from Mount Sinai School of Medicine in 2006 and worked as a Postdoctoral Fellow at Dana-Farber. Inna’s scientific accomplishments include advances in understanding the mechanisms of innate antiviral immunity, signal transduction, and activation of a gene expression program that leads to cellular protection against viruses.
Inna is also an entrepreneur and owns and runs her own family photography business.
Adrienne Wong, PhDTechnology Transfer SpecialistOnY_Wong@dfci.harvard.edu or 617-582-7731
Adrienne joined ORTV in 2014 as a Technology Transfer Specialist. She is responsible for reviewing and negotiating various agreements, as well as helping manage chemistry-related technologies. Prior to joining ORTV, Adrienne conducted postdoctoral research in cancer immunology at Dana-Farber. She received her PhD in Chemistry specializing in Chemical Biology from the University of Illinois at Urbana-Champaign and a BS in Chemistry from the University of Massachusetts/Amherst.
Jing Zhang, PhDTechnology Transfer SpecialistJing_zhang1@dfci.harvard.edu or 617-582-8553
Jing joined ORTV as a Technology Transfer Specialist in 2014. She is responsible for negotiating agreements, as well as monitoring financial post-agreement compliance.
Prior to joining ORTV, Jing worked in the Fellows Program at Harvard University’s Office of Technology Development to conduct early commercialization assessment of inventions. Jing received her BS in Biological Science from the University of Science and Technology of China, and earned her PhD in Chemical Biology from Harvard University. She conducted her graduate and postdoctoral research on oncogenic kinase signaling at Dana-Farber.
Hilary W. Eaton, PhDTechnology Transfer Specialisthilary_eaton@mail.dfci.harvard.edu or 617-632-2118
Hilary joined ORTV as an intern in 2013, and transitioned to a full-time position as a Technology Transfer Specialist in 2014. Before entering the tech transfer field, she completed her postdoctoral research on breast cancer and the progesterone receptor in Myles Brown’s lab in the Department of Medical Oncology at Dana-Farber. Hilary has a PhD in Molecular Cancer Biology from Duke University, and a BS in Zoology and a BA in Spanish from Michigan State University.
Wenting Luo, PhDDatabase Managerwenting_luo@dfci.harvard.edu or 617-582-8542
Wenting joined ORTV in 2013; her responsibilities include managing ORTV’s intellectual property database, and serving on its business development team.
Wenting received her PhD in Biochemistry and Molecular Biology from Rutgers Biomedical and Health Sciences (formerly UMDNJ) in 2012, where she also interned in the Office of Technology Transfer and Business Development. Prior to joining ORTV, she worked as a Technology Licensing Assistant in the Office of Technology Licensing at Princeton University.
Wenting has scientific research experience in various fields of Biomedical Sciences, including immunology, cardiovascular research, systems biology, and RNA biology. She is also an inventor on a patent application describing RNA sequencing technology and disease diagnostics.
Sandra RamirezBusiness Managersandra_ramirez@dfci.harvard.edu or 617-632-5695
Sandra joined ORTV in 1998 and has served as Business Manager for the past seven years, and prior to that as our Fiscal Manager. She is in charge of ORTV’s budget and all accounting functions, including the financial aspects of Industry-Sponsored Research.
Prior to working at Dana-Farber, Sandra worked at the Corporate Office of Filene’s for 13 years in the Shortage Control Office, working with buyers, managers, and the advertising team.
Liza SummaAdministrative Specialistliza_summa@dfci.harvard.edu or 617-632-2594
Liza joined ORTV in 2008. Her duties include assisting the ORTV Business Manager with the tracking of legal expenses and the maintenance of monthly royalty sales reports. Liza also provides office management and administrative assistance to the Chief Business Development Officer.
Before joining Dana-Farber, Liza worked as a Personal Care Attendant and also has considerable work experience in the accounting field.
O. Prem Das, PhD, Chief Research Business Development OfficerGary Sclar, JD, Associate Director
For general questions: firstname.lastname@example.orgFor Academic MTAs: email@example.com
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: